Z2W-50371-80201
5 vaccinations
2 coded responses
37 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 532 / WI
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
-
2021-01-30
Survey response — day 14, dose 1MedDRA: Fatigue, Headache — Feeling: FairFree text: Fatigue, headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Dose 2 — Pfizer-BioNTech
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-22
- 2021-05-08
- 2021-08-07
-
2021-08-17
Dose 3 — Pfizer-BioNTech
-
2021-08-17
Health check-in — day 0, dose 3Feeling: Good · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-08-21
- 2021-08-22
- 2021-08-23
-
2021-08-26
Health check-in — day 7, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-02
- 2021-09-08
-
2021-09-23
Survey response — day 35, dose 3MedDRA: Asthma, Cough, Nasal congestion, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stuffy nose congestion, cough believed to be related to asthmaMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
-
2022-01-17
Dose 4 — Pfizer-BioNTech
-
2022-07-09
Dose 5 — Pfizer-BioNTech
- 2022-07-18
- 2022-07-18
- 2022-07-23
- 2022-08-06
- 2022-10-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2021-08-17 | Pfizer-BioNTech | No |
| 4 | 2022-01-17 | Pfizer-BioNTech | No |
| 5 | 2022-07-09 | Pfizer-BioNTech | No |
Free text
Release 3 — day 14, dose 1
Symptoms: Fatigue, headaches
Release 9 — day 35, dose 3
Symptoms: Stuffy nose congestion, cough believed to be related to asthma
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release